Videos de Conceptos Relacionados
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:27Psychoneuroimmunology: Cardiovascular Disease
77
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
77
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
642
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
642
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Remimazolam Versus Midazolam for Sedation in Mechanically Ventilated Patients with Severe Pneumonia: A Randomized Controlled Trial.
Journal of intensive care medicine·2026
Same author
HO-1-modified umbilical cord MSCs alleviate pulmonary arterial hypertension by reducing inflammation and endothelial dysfunction.
Stem cells translational medicine·2026
Video Experimental Relacionado
Updated: Sep 9, 2025
06:32
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
439
Asociación entre los índices plaquetarios y el riesgo de enfermedad pulmonar obstructiva crónica: un estudio
Weifeng Liao1, Xiaoxi Lin1, Keyu Liu2
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524003, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|September 4, 2025
Resumen
Este estudio de aleatorización mendeliana no encontró una relación causal definitiva entre los índices plaquetarios y la EPOC. Sin embargo, el recuento más alto de plaquetas y el plaquetecrito mostraron una asociación sugerente con un mayor riesgo de EPOC.
Palabras clave:
enfermedad pulmonar obstructiva crónicavolumen medio de plaquetasLa aleatorización mendelianaCuenta de plaquetasAncho de distribución de las plaquetasPlaquetascritoMás Videos Relacionados
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
19.2K
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.1K
Área de la Ciencia:
- Genética y genómica
- Medicina de los pulmones
- Hematología
Sus antecedentes:
- Los índices plaquetarios están relacionados con la enfermedad pulmonar obstructiva crónica (EPOC), pero no se han establecido relaciones causales.
- La investigación de los vínculos genéticos puede aclarar las vías etiológicas de la EPOC.
- Los índices de plaquetas como el recuento de plaquetas (PLT), el plateletcrit (PCT), el volumen medio de plaquetas (MPV) y el ancho de distribución de plaquetas (PDW) son factores potenciales.
Objetivo del estudio:
- Explorar las posibles relaciones causales entre los índices plaquetarios comunes y la EPOC utilizando un enfoque bidireccional de aleatorización mendeliana (MR).
- Evaluar la influencia genética de PLT, PCT, MPV y PDW en el riesgo de EPOC y viceversa.
- Determinar si la predisposición genética a índices plaquetarios alterados tiene un impacto causal en el desarrollo de la EPOC.
Principales métodos:
- Se utilizaron estadísticas resumidas de grandes estudios de asociación de todo el genoma (GWAS) para los índices plaquetarios (UK Biobank) y la EPOC (FinnGen) en poblaciones de ascendencia europea.
- Utilizó varios métodos de RM, incluida la ponderación de variación inversa (IVW), MR Egger y otros para evaluar los efectos causales.
- Se han realizado análisis de sensibilidad (intercepción de Cochran, MR-Egger, MR-PRESSO, leave-one-out) para comprobar la heterogeneidad, la pleiotropía y la robustez.
Principales resultados:
- La evidencia sugerente indicó que un mayor recuento plaquetario (PLT) está asociado con un mayor riesgo de EPOC (OR = 1, 054).
- El análisis de resonancia magnética inversa sugirió que la EPOC está asociada con un aumento del plaquetecrito (PCT) (OR = 1,025).
- No se encontraron asociaciones causales significativas para el volumen promedio de plaquetas (MPV) o el ancho de distribución plaquetaria (PDW); los análisis de sensibilidad confirmaron la solidez de los resultados.
Conclusiones:
- Este estudio de RM bidireccional no estableció una relación causal definitiva entre los índices plaquetarios y la EPOC.
- Las asociaciones sugerentes entre el aumento de PLT/PCT y el aumento del riesgo de EPOC merecen una investigación adicional.
- Los índices plaquetarios pueden desempeñar un papel en la patogénesis de la EPOC, sirviendo potencialmente como futuros biomarcadores o dianas terapéuticas.